These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 35699166)
21. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis. Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382 [TBL] [Abstract][Full Text] [Related]
23. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro. Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457 [TBL] [Abstract][Full Text] [Related]
24. Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination. Lee WJ; Lan KH; Chou CT; Yi YC; Chen WC; Pan HC; Peng YC; Wang KB; Chen YC; Chao TH; Tien HR; Sheu WH; Sheu ML Neoplasia; 2013 Sep; 15(9):1036-48. PubMed ID: 24027429 [TBL] [Abstract][Full Text] [Related]
25. Genome-wide approaches reveal functional vascular endothelial growth factor (VEGF)-inducible nuclear factor of activated T cells (NFAT) c1 binding to angiogenesis-related genes in the endothelium. Suehiro J; Kanki Y; Makihara C; Schadler K; Miura M; Manabe Y; Aburatani H; Kodama T; Minami T J Biol Chem; 2014 Oct; 289(42):29044-59. PubMed ID: 25157100 [TBL] [Abstract][Full Text] [Related]
26. The activation of RhoC in vascular endothelial cells is required for the S1P receptor type 2-induced inhibition of angiogenesis. Del Galdo S; Vettel C; Heringdorf DM; Wieland T Cell Signal; 2013 Dec; 25(12):2478-84. PubMed ID: 23993968 [TBL] [Abstract][Full Text] [Related]
27. Regulation of RhoA activity by the cellular prion protein. Kim HJ; Choi HS; Park JH; Kim MJ; Lee HG; Petersen RB; Kim YS; Park JB; Choi EK Cell Death Dis; 2017 Mar; 8(3):e2668. PubMed ID: 28300846 [TBL] [Abstract][Full Text] [Related]
28. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway. Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703 [TBL] [Abstract][Full Text] [Related]
29. RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response. Wang J; Liu H; Chen B; Li Q; Huang X; Wang L; Guo X; Huang Q Cardiovasc Diabetol; 2012 Jan; 11():7. PubMed ID: 22251897 [TBL] [Abstract][Full Text] [Related]
30. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis. Saraswati S; Kanaujia PK; Kumar S; Kumar R; Alhaider AA Mol Cancer; 2013 Jul; 12():82. PubMed ID: 23895055 [TBL] [Abstract][Full Text] [Related]
31. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation. Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804 [TBL] [Abstract][Full Text] [Related]
32. Endothelial RhoA GTPase is essential for in vitro endothelial functions but dispensable for physiological in vivo angiogenesis. Zahra FT; Sajib MS; Ichiyama Y; Akwii RG; Tullar PE; Cobos C; Minchew SA; Doçi CL; Zheng Y; Kubota Y; Gutkind JS; Mikelis CM Sci Rep; 2019 Aug; 9(1):11666. PubMed ID: 31406143 [TBL] [Abstract][Full Text] [Related]
33. PAR1 regulates sepsis-induced vascular endothelial barrier dysfunction by mediating ERM phosphorylation via the RhoA/ROCK signaling pathway. Zhao L; Hu J; Zheng P; Mi B; Chen Z; Zhao X; Wu J; Wang Y Int Immunopharmacol; 2023 Nov; 124(Pt B):110992. PubMed ID: 37806106 [TBL] [Abstract][Full Text] [Related]
34. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by Huang B; Huang M; Li Q Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187 [TBL] [Abstract][Full Text] [Related]
36. Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis. Chillà A; Margheri F; Biagioni A; Del Rosso M; Fibbi G; Laurenzana A J Exp Clin Cancer Res; 2018 Apr; 37(1):74. PubMed ID: 29615071 [TBL] [Abstract][Full Text] [Related]
37. KDR stimulates endothelial cell migration through heterotrimeric G protein Gq/11-mediated activation of a small GTPase RhoA. Zeng H; Zhao D; Mukhopadhyay D J Biol Chem; 2002 Nov; 277(48):46791-8. PubMed ID: 12244099 [TBL] [Abstract][Full Text] [Related]
38. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970 [TBL] [Abstract][Full Text] [Related]
40. Advanced glycosylation end products (AGEs) controls proliferation, invasion and permeability through orchestrating ARHGAP18/RhoA pathway in human umbilical vein endothelial cells. Li X; Tao Y; Wang X; Wang T; Liu J Glycoconj J; 2020 Apr; 37(2):209-219. PubMed ID: 32016689 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]